Kenichi Inoue

Most-cited papers

1. The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2: A Randomized Clinical Trial

   G. Sledge, M. Toi, Kenichi Inoue, P. Kaufman

   2019237 citations

   Semantic Scholar

   Save

2. Abemaciclib Plus Fulvestrant in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Final Overall Survival Results From MONARCH 2

   P. Neven, M. Toi, J. Sohn, Kenichi Inoue +12 more

   2025JCO Oncology Advances5 citations Open access

   Semantic Scholar

   Save

3. Pembrolizumab for Early‐Stage Triple‐Negative Breast Cancer: KEYNOTE‐522 Japan Subgroup Analysis

   Masato Takahashi, H. Mukai, T. Takano, K. Tsugawa +13 more

   2026Cancer Science2 citations Open access

   Semantic Scholar

   Save

4. Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancer

   T. Ueno, L. Chow, Wonshik Han, Chiun-Sheng Huang +30 more

   2025Endocrine-Related Cancer1 citations

   Semantic Scholar

   Save

5. Cultural Adaptation and Preliminary Validation of Adherence Questionnaires for Japanese Patients with Breast Cancer: A Pilot Study

   A. Matsuda, K. Tozuka, Manami Momiyama, Kenichi Inoue +4 more

   2025Patient Preference and Adherence0 citations Open access

   Semantic Scholar

   Save